Exosomes Market By Offering (Exosomes Tools & Kits, Exosomes Antibodies, Exosomes Reagents and Others); By Applications (Diagnostics and Therapeutics); By Disease Indications (Cancer, Cardiovascular, Endocrinology, Neurodegenerative Diseases, Infectious Diseases, and Others); By End Users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia(Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia) Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Exosomes are widely used as a therapeutic drug carriers and delivery vehicles and are therefore used to treat various chronic diseases. The use of exosomes as drug delivery vehicles offers important advantages compared to other drug delivery systems such as liposomes and polymeric nanoparticle. The global exosomes market is driven by the rising prevalence of chronic diseases such as cancer and cardiovascular diseases (CVDs) across the globe. According to the data published by the National Center for Health Statistics, 1,898,160 new cancer cases and 608,570 cancer deaths were projected in the United States in 2021. The rising burden of cancer is the major factor contributing to the exosomes market growth. Exosomes show great promise in cancer immunotherapy because of their immunogenicity and molecular transfer function. Also, exosomes derived from specific sites of the body are promising candidates for anti-cancer vaccines due to the enhanced passive targeting, owing to their small size, indigenous nature, and the ability to cross the biological barriers.
The outbreak of COVID19 has created an opportunity for the exosomes market since they exhibit promising potential to combat the spread of the coronavirus. Exosomes offer a novel mode of delivery that not only deliver antiviral drugs, but also deliver their native cargo components, and hence can be potentially used for the treating COVID 19. Moreover, recent advances in loading and modification of therapeutic exosomes is fuelling the market. Rapid development of bio-nanoparticles and confluent advances in next-generation diagnostics, monitoring the progression of several diseases, and accurate guidance for therapy is anticipated to boost the market growth over the forecast period.
In terms of revenue, exosomes market was valued at US$ 471.69 Mn in 2021 growing at a CAGR of 17.6% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Exosomes Market Revenue & Forecast, (US$ Million), 2015 – 2030
By Offering
On the basis of offering, the exosomes market is bifurcated into exosomes tools and kits, exosomes reagents, exosomes antibodies, and others. The exosomes tools and kits and reagents accounted for the largest market share in 2021. Growing demand for liquid biopsy tests, increasing basic research and commercial applications of exosomes, along with the need for reliable and specific diagnostic assays is contributing towards the segment’s growth in the global market.
By Applications
Based on applications, the exosomes market is bifurcated into diagnostics and therapeutics. The therapeutics segment dominated the market in 2021. Exosomes serve as a therapeutic platform for many diseases such as cancer, neurodegenerative diseases, cardiovascular diseases, etc. Moreover, the stem cell-derived exosomes are advantageous in harnessing the anti-inflammatory and regenerative abilities of parent cells; thus, exosomal treatment can be engineered for respiratory viral diseases, including SARS-CoV-2.
By Disease Indication
Based on disease indication, the exosomes market is classified into cancer, cardiovascular, endocrinology, neurodegenerative diseases, infectious diseases, and others. Cancer as a disease indication dominated the market in 2021, owing to increasing number of cancer patients, globally. The increasing prevalence of lung cancer, technological advancements in instruments & assays for liquid biopsy, and the growing demand for advanced diagnostic technologies for cancer is impelling the market.
By End Users
On the basis of end-user, the exosomes market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, others. The academic & research institutes accounted for the largest market share in 2021, owing to increasing number of cancer and stem cell research projects across the globe, wherein exosomes are used extensively. Moreover, the rising public-private funding for exosome-based research is contributing to the growth of this end-user segment in the global market.
By Region
North American region held the largest share in the global exosomes market in 2021. This dominance is attributed to the strong healthcare infrastructure, effective government policies, and a huge base of multinational companies in the region. Moreover, large number of government-funded research studies are being conducted in the region, regarding the role of drugs using exosomes for several kinds of cancers, such as melanoma, breast cancer, lung cancer, and pancreatic cancer, etc., which is thereby impelling the market growth.
Competitive Landscape
The report provides both, qualitative and quantitative research of the global exosomes market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyses in the report. For each company, the report studies their global presence, competitors, service offerings, and specification amongst others.
Some of the key players operating in the global exosomes market are:
- AMSBIO
- BioVision Inc.
- ExoDx
- FUJIFILM Wako Pure Chemical Corporation
- Lonza
- Miltenyi Biotec
- Norgen Biotek Corp.
- QIAGEN
- System Biosciences, LLC
- Takara Bio Inc.
- Thermo Fisher Scientific
- ZenBio, Inc.
- Other Market Participants
Global Exosomes Market
- By Offering
- Exosomes Tools and Kits
- Exosomes Reagents
- Exosomes Antibodies
- Others
- By Application
- Diagnostics
- Therapeutic
- By Disease Indication
- Cancer
- Cardiovascular
- Endocrinology
- Neurodegenerative Diseases
- Infectious Diseases
- Others
- By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Exosomes Market
6. Market Synopsis:
Exosomes Market
7. Exosomes Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Exosomes Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Exosomes Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Exosomes Market
8. Global Exosomes Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global
Exosomes Market Revenue (US$ Mn)
8.2. Global
Exosomes Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1. Exosomes
Tools and Kits
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2021
8.2.1.3. Market Forecast, 2022 - 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022 - 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022 - 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022 - 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022 - 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022 - 2030
8.2.2. Exosomes
Reagents
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 - 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 - 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 - 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 - 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 - 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 - 2030
8.2.3. Exosomes
Antibodies
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2021
8.2.3.3. Market Forecast, 2022 - 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 - 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 - 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 - 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 - 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 - 2030
8.2.4. Others
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2021
8.2.4.3. Market Forecast, 2022 - 2030
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 - 2021
8.2.4.5.1.2. Market
Forecast, 2022 - 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2021
8.2.4.5.2.2. Market
Forecast, 2022 - 2030
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2021
8.2.4.5.3.2. Market
Forecast, 2022 - 2030
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2021
8.2.4.5.4.2. Market
Forecast, 2022 - 2030
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 - 2021
8.2.4.5.5.2. Market
Forecast, 2022 - 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global Exosomes Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global
Exosomes Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Diagnostics
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 - 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 - 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 - 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 - 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 - 2030
9.2.2. Therapeutic
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 - 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 - 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 - 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 - 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 - 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. Global Exosomes Market Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global
Exosomes Market Revenue (US$ Mn) and Forecasts, By Disease Indication
10.2.1. Cancer
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2021
10.2.1.3. Market Forecast, 2022 - 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022 - 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022 - 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 - 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022 - 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022 - 2030
10.2.2. Cardiovascular
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2021
10.2.2.3. Market Forecast, 2022 - 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 - 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 - 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 - 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 - 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 - 2030
10.2.3. Endocrinology
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2021
10.2.3.3. Market Forecast, 2022 - 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022 - 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022 - 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2021
10.2.3.5.3.2. Market
Forecast, 2022 - 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022 - 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022 - 2030
10.2.4. Neurodegenerative
Diseases
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2021
10.2.4.3. Market Forecast, 2022 - 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022 - 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022 - 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2021
10.2.4.5.3.2. Market
Forecast, 2022 - 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2021
10.2.4.5.4.2. Market
Forecast, 2022 - 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022 - 2030
10.2.5. Infectious
Diseases
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2021
10.2.5.3. Market Forecast, 2022 - 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2015 - 2021
10.2.5.5.1.2. Market
Forecast, 2022 - 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 - 2021
10.2.5.5.2.2. Market
Forecast, 2022 - 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2015 - 2021
10.2.5.5.3.2. Market
Forecast, 2022 - 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 - 2021
10.2.5.5.4.2. Market
Forecast, 2022 - 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2015 - 2021
10.2.5.5.5.2. Market
Forecast, 2022 - 2030
10.2.6. Others
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 - 2021
10.2.6.3. Market Forecast, 2022 - 2030
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market
Estimation, 2015 - 2021
10.2.6.5.1.2. Market
Forecast, 2022 - 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 - 2021
10.2.6.5.2.2. Market
Forecast, 2022 - 2030
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market
Estimation, 2015 - 2021
10.2.6.5.3.2. Market
Forecast, 2022 - 2030
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 - 2021
10.2.6.5.4.2. Market
Forecast, 2022 - 2030
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market
Estimation, 2015 - 2021
10.2.6.5.5.2. Market
Forecast, 2022 - 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Disease Indication
11. Global Exosomes Market Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global
Exosomes Market Revenue (US$ Mn) and Forecasts, By End User
11.2.1. Pharmaceutical
and Biotechnology Companies
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2021
11.2.1.3. Market Forecast, 2022 - 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 - 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 - 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 - 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 - 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 - 2030
11.2.2. Academic
and Research Institutes
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2021
11.2.2.3. Market Forecast, 2022 - 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 - 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 - 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 - 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 - 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 - 2030
11.2.3. Others
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2021
11.2.3.3. Market Forecast, 2022 - 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2021
11.2.3.5.1.2. Market
Forecast, 2022 - 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2021
11.2.3.5.2.2. Market
Forecast, 2022 - 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2021
11.2.3.5.3.2. Market
Forecast, 2022 - 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2021
11.2.3.5.4.2. Market
Forecast, 2022 - 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2021
11.2.3.5.5.2. Market
Forecast, 2022 - 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By End User
12. Global Exosomes Market Analysis and Forecasts, 2022 – 2030
12.1. Overview
12.2. Global
Exosomes Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.2.1. Online
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 - 2021
12.2.1.3. Market Forecast, 2022 - 2030
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North America
12.2.1.5.1.1. Market
Estimation, 2015 - 2021
12.2.1.5.1.2. Market
Forecast, 2022 - 2030
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 - 2021
12.2.1.5.2.2. Market
Forecast, 2022 - 2030
12.2.1.5.3. Asia Pacific
12.2.1.5.3.1. Market
Estimation, 2015 - 2021
12.2.1.5.3.2. Market
Forecast, 2022 - 2030
12.2.1.5.4. Middle East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 - 2021
12.2.1.5.4.2. Market
Forecast, 2022 - 2030
12.2.1.5.5. Latin America
12.2.1.5.5.1. Market
Estimation, 2015 - 2021
12.2.1.5.5.2. Market
Forecast, 2022 - 2030
12.2.2. Offline
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 - 2021
12.2.2.3. Market Forecast, 2022 - 2030
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North America
12.2.2.5.1.1. Market
Estimation, 2015 - 2021
12.2.2.5.1.2. Market
Forecast, 2022 - 2030
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 - 2021
12.2.2.5.2.2. Market
Forecast, 2022 - 2030
12.2.2.5.3. Asia Pacific
12.2.2.5.3.1. Market
Estimation, 2015 - 2021
12.2.2.5.3.2. Market
Forecast, 2022 - 2030
12.2.2.5.4. Middle East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 - 2021
12.2.2.5.4.2. Market
Forecast, 2022 - 2030
12.2.2.5.5. Latin America
12.2.2.5.5.1. Market
Estimation, 2015 - 2021
12.2.2.5.5.2. Market
Forecast, 2022 - 2030
12.3. Key
Segment for Channeling Investments
12.3.1. By
Distribution Channel
13. North America Exosomes Market Analysis and Forecasts, 2022 -
2030
13.1. Overview
13.1.1. North
America Exosomes Market Revenue (US$ Mn)
13.2. North
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Exosomes
Tools and Kits
13.2.2. Exosomes
Reagents
13.2.3. Exosomes
Antibodies
13.2.4. Others
13.3. North
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1. Diagnostics
13.3.2. Therapeutic
13.4. North
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Disease Indication
13.4.1. Cancer
13.4.2. Cardiovascular
13.4.3. Endocrinology
13.4.4. Neurodegenerative
Diseases
13.4.5. Infectious
Diseases
13.4.6. Others
13.5. North
America Exosomes Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1. Pharmaceutical
and Biotechnology Companies
13.5.2. Academic
and Research Institutes
13.5.3. Others
13.6. North
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
13.6.1. Online
13.6.2. Offline
13.7. North
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
13.7.1.1.1. Exosomes Tools and Kits
13.7.1.1.2. Exosomes Reagents
13.7.1.1.3. Exosomes Antibodies
13.7.1.1.4. Others
13.7.1.2. U.S Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.1.2.1. Diagnostics
13.7.1.2.2. Therapeutic
13.7.1.3. U.S Exosomes Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
13.7.1.3.1. Cancer
13.7.1.3.2. Cardiovascular
13.7.1.3.3. Endocrinology
13.7.1.3.4. Neurodegenerative Diseases
13.7.1.3.5. Infectious Diseases
13.7.1.3.6. Others
13.7.1.4. U.S Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
13.7.1.4.1. Pharmaceutical and Biotechnology Companies
13.7.1.4.2. Academic and Research Institutes
13.7.1.4.3. Others
13.7.1.5. U.S Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.7.1.5.1. Online
13.7.1.5.2. Offline
13.7.2. Canada
13.7.2.1. Canada Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
13.7.2.1.1. Exosomes Tools and Kits
13.7.2.1.2. Exosomes Reagents
13.7.2.1.3. Exosomes Antibodies
13.7.2.1.4. Others
13.7.2.2. Canada Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.2.2.1. Diagnostics
13.7.2.2.2. Therapeutic
13.7.2.3. Canada Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
13.7.2.3.1. Cancer
13.7.2.3.2. Cardiovascular
13.7.2.3.3. Endocrinology
13.7.2.3.4. Neurodegenerative Diseases
13.7.2.3.5. Infectious Diseases
13.7.2.3.6. Others
13.7.2.4. Canada Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
13.7.2.4.1. Pharmaceutical and Biotechnology Companies
13.7.2.4.2. Academic and Research Institutes
13.7.2.4.3. Others
13.7.2.5. Canada Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.7.2.5.1. Online
13.7.2.5.2. Offline
13.7.3. Mexico
13.7.3.1. Mexico Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
13.7.3.1.1. Exosomes Tools and Kits
13.7.3.1.2. Exosomes Reagents
13.7.3.1.3. Exosomes Antibodies
13.7.3.1.4. Others
13.7.3.2. Mexico Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.3.2.1. Diagnostics
13.7.3.2.2. Therapeutic
13.7.3.3. Mexico Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
13.7.3.3.1. Cancer
13.7.3.3.2. Cardiovascular
13.7.3.3.3. Endocrinology
13.7.3.3.4. Neurodegenerative Diseases
13.7.3.3.5. Infectious Diseases
13.7.3.3.6. Others
13.7.3.4. Mexico Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
13.7.3.4.1. Pharmaceutical and Biotechnology Companies
13.7.3.4.2. Academic and Research Institutes
13.7.3.4.3. Others
13.7.3.5. Mexico Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.7.3.5.1. Online
13.7.3.5.2. Offline
13.7.4. Rest of
North America
13.7.4.1. Rest of North America Exosomes Market Revenue (US$ Mn) and
Forecasts, By Offering
13.7.4.1.1. Exosomes Tools and Kits
13.7.4.1.2. Exosomes Reagents
13.7.4.1.3. Exosomes Antibodies
13.7.4.1.4. Others
13.7.4.2. Rest of North America Exosomes Market Revenue (US$ Mn) and
Forecasts, By Application
13.7.4.2.1. Diagnostics
13.7.4.2.2. Therapeutic
13.7.4.3. Rest of North America Exosomes Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
13.7.4.3.1. Cancer
13.7.4.3.2. Cardiovascular
13.7.4.3.3. Endocrinology
13.7.4.3.4. Neurodegenerative Diseases
13.7.4.3.5. Infectious Diseases
13.7.4.3.6. Others
13.7.4.4. Rest of North America Exosomes Market Revenue (US$ Mn) and
Forecasts, By End User
13.7.4.4.1. Pharmaceutical and Biotechnology Companies
13.7.4.4.2. Academic and Research Institutes
13.7.4.4.3. Others
13.7.4.5. Rest of North America Exosomes Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.7.4.5.1. Online
13.7.4.5.2. Offline
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By
Offering
13.8.3. By
Application
13.8.4. By
Disease Indication
13.8.5. By End
User
13.8.6. By
Distribution Channel
14. Europe Exosomes Market Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Europe
Exosomes Market Revenue (US$ Mn)
14.2. Europe
Exosomes Market Revenue (US$ Mn) and Forecasts, By Offering
14.2.1. Exosomes
Tools and Kits
14.2.2. Exosomes
Reagents
14.2.3. Exosomes
Antibodies
14.2.4. Others
14.3. Europe
Exosomes Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1. Diagnostics
14.3.2. Therapeutic
14.4. Europe
Exosomes Market Revenue (US$ Mn) and Forecasts, By Disease Indication
14.4.1. Cancer
14.4.2. Cardiovascular
14.4.3. Endocrinology
14.4.4. Neurodegenerative
Diseases
14.4.5. Infectious
Diseases
14.4.6. Others
14.5. Europe
Exosomes Market Revenue (US$ Mn) and Forecasts, By End User
14.5.1. Pharmaceutical
and Biotechnology Companies
14.5.2. Academic
and Research Institutes
14.5.3. Others
14.6. Europe
Exosomes Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.6.1. Online
14.6.2. Offline
14.7. Europe
Exosomes Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
14.7.1.1.1. Exosomes Tools and Kits
14.7.1.1.2. Exosomes Reagents
14.7.1.1.3. Exosomes Antibodies
14.7.1.1.4. Others
14.7.1.2. France Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.1.2.1. Diagnostics
14.7.1.2.2. Therapeutic
14.7.1.3. France Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
14.7.1.3.1. Cancer
14.7.1.3.2. Cardiovascular
14.7.1.3.3. Endocrinology
14.7.1.3.4. Neurodegenerative Diseases
14.7.1.3.5. Infectious Diseases
14.7.1.3.6. Others
14.7.1.4. France Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
14.7.1.4.1. Pharmaceutical and Biotechnology Companies
14.7.1.4.2. Academic and Research Institutes
14.7.1.4.3. Others
14.7.1.5. France Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.1.5.1. Online
14.7.1.5.2. Offline
14.7.2. The UK
14.7.2.1. The UK Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
14.7.2.1.1. Exosomes Tools and Kits
14.7.2.1.2. Exosomes Reagents
14.7.2.1.3. Exosomes Antibodies
14.7.2.1.4. Others
14.7.2.2. The UK Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.2.2.1. Diagnostics
14.7.2.2.2. Therapeutic
14.7.2.3. The UK Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
14.7.2.3.1. Cancer
14.7.2.3.2. Cardiovascular
14.7.2.3.3. Endocrinology
14.7.2.3.4. Neurodegenerative Diseases
14.7.2.3.5. Infectious Diseases
14.7.2.3.6. Others
14.7.2.4. The UK Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
14.7.2.4.1. Pharmaceutical and Biotechnology Companies
14.7.2.4.2. Academic and Research Institutes
14.7.2.4.3. Others
14.7.2.5. The UK Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.2.5.1. Online
14.7.2.5.2. Offline
14.7.3. Spain
14.7.3.1. Spain Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
14.7.3.1.1. Exosomes Tools and Kits
14.7.3.1.2. Exosomes Reagents
14.7.3.1.3. Exosomes Antibodies
14.7.3.1.4. Others
14.7.3.2. Spain Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.3.2.1. Diagnostics
14.7.3.2.2. Therapeutic
14.7.3.3. Spain Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
14.7.3.3.1. Cancer
14.7.3.3.2. Cardiovascular
14.7.3.3.3. Endocrinology
14.7.3.3.4. Neurodegenerative Diseases
14.7.3.3.5. Infectious Diseases
14.7.3.3.6. Others
14.7.3.4. Spain Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
14.7.3.4.1. Pharmaceutical and Biotechnology Companies
14.7.3.4.2. Academic and Research Institutes
14.7.3.4.3. Others
14.7.3.5. Spain Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.3.5.1. Online
14.7.3.5.2. Offline
14.7.4. Germany
14.7.4.1. Germany Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
14.7.4.1.1. Exosomes Tools and Kits
14.7.4.1.2. Exosomes Reagents
14.7.4.1.3. Exosomes Antibodies
14.7.4.1.4. Others
14.7.4.2. Germany Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.4.2.1. Diagnostics
14.7.4.2.2. Therapeutic
14.7.4.3. Germany Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
14.7.4.3.1. Cancer
14.7.4.3.2. Cardiovascular
14.7.4.3.3. Endocrinology
14.7.4.3.4. Neurodegenerative Diseases
14.7.4.3.5. Infectious Diseases
14.7.4.3.6. Others
14.7.4.4. Germany Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
14.7.4.4.1. Pharmaceutical and Biotechnology Companies
14.7.4.4.2. Academic and Research Institutes
14.7.4.4.3. Others
14.7.4.5. Germany Exosomes Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.7.4.5.1. Online
14.7.4.5.2. Offline
14.7.5. Italy
14.7.5.1. Italy Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
14.7.5.1.1. Exosomes Tools and Kits
14.7.5.1.2. Exosomes Reagents
14.7.5.1.3. Exosomes Antibodies
14.7.5.1.4. Others
14.7.5.2. Italy Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.5.2.1. Diagnostics
14.7.5.2.2. Therapeutic
14.7.5.3. Italy Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
14.7.5.3.1. Cancer
14.7.5.3.2. Cardiovascular
14.7.5.3.3. Endocrinology
14.7.5.3.4. Neurodegenerative Diseases
14.7.5.3.5. Infectious Diseases
14.7.5.3.6. Others
14.7.5.4. Italy Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
14.7.5.4.1. Pharmaceutical and Biotechnology Companies
14.7.5.4.2. Academic and Research Institutes
14.7.5.4.3. Others
14.7.5.5. Italy Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.7.5.5.1. Online
14.7.5.5.2. Offline
14.7.6. Nordic
Countries
14.7.6.1. Nordic Countries Exosomes Market Revenue (US$ Mn) and
Forecasts, By Offering
14.7.6.1.1. Exosomes Tools and Kits
14.7.6.1.2. Exosomes Reagents
14.7.6.1.3. Exosomes Antibodies
14.7.6.1.4. Others
14.7.6.2. Nordic Countries Exosomes Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.6.2.1. Diagnostics
14.7.6.2.2. Therapeutic
14.7.6.3. Nordic Countries Exosomes Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
14.7.6.3.1. Cancer
14.7.6.3.2. Cardiovascular
14.7.6.3.3. Endocrinology
14.7.6.3.4. Neurodegenerative Diseases
14.7.6.3.5. Infectious Diseases
14.7.6.3.6. Others
14.7.6.4. Nordic Countries Exosomes Market Revenue (US$ Mn) and
Forecasts, By End User
14.7.6.4.1. Pharmaceutical and Biotechnology Companies
14.7.6.4.2. Academic and Research Institutes
14.7.6.4.3. Others
14.7.6.5. Nordic Countries Exosomes Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.7.6.5.1. Online
14.7.6.5.2. Offline
14.7.6.6. Nordic Countries Exosomes Market Revenue (US$ Mn) and
Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux Union Exosomes Market Revenue (US$ Mn) and Forecasts,
By Offering
14.7.7.1.1. Exosomes Tools and Kits
14.7.7.1.2. Exosomes Reagents
14.7.7.1.3. Exosomes Antibodies
14.7.7.1.4. Others
14.7.7.2. Benelux Union Exosomes Market Revenue (US$ Mn) and Forecasts,
By Application
14.7.7.2.1. Diagnostics
14.7.7.2.2. Therapeutic
14.7.7.3. Benelux Union Exosomes Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
14.7.7.3.1. Cancer
14.7.7.3.2. Cardiovascular
14.7.7.3.3. Endocrinology
14.7.7.3.4. Neurodegenerative Diseases
14.7.7.3.5. Infectious Diseases
14.7.7.3.6. Others
14.7.7.4. Benelux Union Exosomes Market Revenue (US$ Mn) and Forecasts,
By End User
14.7.7.4.1. Pharmaceutical and Biotechnology Companies
14.7.7.4.2. Academic and Research Institutes
14.7.7.4.3. Others
14.7.7.5. Benelux Union Exosomes Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
14.7.7.5.1. Online
14.7.7.5.2. Offline
14.7.7.6. Benelux Union Exosomes Market Revenue (US$ Mn) and Forecasts,
By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest of Europe Exosomes Market Revenue (US$ Mn) and Forecasts,
By Offering
14.7.8.1.1. Exosomes Tools and Kits
14.7.8.1.2. Exosomes Reagents
14.7.8.1.3. Exosomes Antibodies
14.7.8.1.4. Others
14.7.8.2. Rest of Europe Exosomes Market Revenue (US$ Mn) and Forecasts,
By Application
14.7.8.2.1. Diagnostics
14.7.8.2.2. Therapeutic
14.7.8.3. Rest of Europe Exosomes Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
14.7.8.3.1. Cancer
14.7.8.3.2. Cardiovascular
14.7.8.3.3. Endocrinology
14.7.8.3.4. Neurodegenerative Diseases
14.7.8.3.5. Infectious Diseases
14.7.8.3.6. Others
14.7.8.4. Rest of Europe Exosomes Market Revenue (US$ Mn) and Forecasts,
By End User
14.7.8.4.1. Pharmaceutical and Biotechnology Companies
14.7.8.4.2. Academic and Research Institutes
14.7.8.4.3. Others
14.7.8.5. Rest of Europe Exosomes Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
14.7.8.5.1. Online
14.7.8.5.2. Offline
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By
Offering
14.8.3. By
Application
14.8.4. By
Disease Indication
14.8.5. By End
User
14.8.6. By
Distribution Channel
15. Asia Pacific Exosomes Market Analysis and Forecasts, 2022 -
2030
15.1. Overview
15.1.1. Asia
Pacific Exosomes Market Revenue (US$ Mn)
15.2. Asia
Pacific Exosomes Market Revenue (US$ Mn) and Forecasts, By Offering
15.2.1. Exosomes
Tools and Kits
15.2.2. Exosomes
Reagents
15.2.3. Exosomes
Antibodies
15.2.4. Others
15.3. Asia
Pacific Exosomes Market Revenue (US$ Mn) and Forecasts, By Application
15.3.1. Diagnostics
15.3.2. Therapeutic
15.4. Asia
Pacific Exosomes Market Revenue (US$ Mn) and Forecasts, By Disease Indication
15.4.1. Cancer
15.4.2. Cardiovascular
15.4.3. Endocrinology
15.4.4. Neurodegenerative
Diseases
15.4.5. Infectious
Diseases
15.4.6. Others
15.5. Asia
Pacific Exosomes Market Revenue (US$ Mn) and Forecasts, By End User
15.5.1. Pharmaceutical
and Biotechnology Companies
15.5.2. Academic
and Research Institutes
15.5.3. Others
15.6. Asia
Pacific Exosomes Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.6.1. Online
15.6.2. Offline
15.7. Asia
Pacific Exosomes Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1. China Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
15.7.1.1.1. Exosomes Tools and Kits
15.7.1.1.2. Exosomes Reagents
15.7.1.1.3. Exosomes Antibodies
15.7.1.1.4. Others
15.7.1.2. China Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.1.2.1. Diagnostics
15.7.1.2.2. Therapeutic
15.7.1.3. China Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
15.7.1.3.1. Cancer
15.7.1.3.2. Cardiovascular
15.7.1.3.3. Endocrinology
15.7.1.3.4. Neurodegenerative Diseases
15.7.1.3.5. Infectious Diseases
15.7.1.3.6. Others
15.7.1.4. China Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
15.7.1.4.1. Pharmaceutical and Biotechnology Companies
15.7.1.4.2. Academic and Research Institutes
15.7.1.4.3. Others
15.7.1.5. China Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.1.5.1. Online
15.7.1.5.2. Offline
15.7.2. Japan
15.7.2.1. Japan Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
15.7.2.1.1. Exosomes Tools and Kits
15.7.2.1.2. Exosomes Reagents
15.7.2.1.3. Exosomes Antibodies
15.7.2.1.4. Others
15.7.2.2. Japan Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.2.2.1. Diagnostics
15.7.2.2.2. Therapeutic
15.7.2.3. Japan Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
15.7.2.3.1. Cancer
15.7.2.3.2. Cardiovascular
15.7.2.3.3. Endocrinology
15.7.2.3.4. Neurodegenerative Diseases
15.7.2.3.5. Infectious Diseases
15.7.2.3.6. Others
15.7.2.4. Japan Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
15.7.2.4.1. Pharmaceutical and Biotechnology Companies
15.7.2.4.2. Academic and Research Institutes
15.7.2.4.3. Others
15.7.2.5. Japan Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.2.5.1. Online
15.7.2.5.2. Offline
15.7.3. India
15.7.3.1. India Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
15.7.3.1.1. Exosomes Tools and Kits
15.7.3.1.2. Exosomes Reagents
15.7.3.1.3. Exosomes Antibodies
15.7.3.1.4. Others
15.7.3.2. India Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.3.2.1. Diagnostics
15.7.3.2.2. Therapeutic
15.7.3.3. India Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
15.7.3.3.1. Cancer
15.7.3.3.2. Cardiovascular
15.7.3.3.3. Endocrinology
15.7.3.3.4. Neurodegenerative Diseases
15.7.3.3.5. Infectious Diseases
15.7.3.3.6. Others
15.7.3.4. India Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
15.7.3.4.1. Pharmaceutical and Biotechnology Companies
15.7.3.4.2. Academic and Research Institutes
15.7.3.4.3. Others
15.7.3.5. India Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.3.5.1. Online
15.7.3.5.2. Offline
15.7.4. New
Zealand
15.7.4.1. New Zealand Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
15.7.4.1.1. Exosomes Tools and Kits
15.7.4.1.2. Exosomes Reagents
15.7.4.1.3. Exosomes Antibodies
15.7.4.1.4. Others
15.7.4.2. New Zealand Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.4.2.1. Diagnostics
15.7.4.2.2. Therapeutic
15.7.4.3. New Zealand Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
15.7.4.3.1. Cancer
15.7.4.3.2. Cardiovascular
15.7.4.3.3. Endocrinology
15.7.4.3.4. Neurodegenerative Diseases
15.7.4.3.5. Infectious Diseases
15.7.4.3.6. Others
15.7.4.4. New Zealand Exosomes Market Revenue (US$ Mn) and Forecasts, By
End User
15.7.4.4.1. Pharmaceutical and Biotechnology Companies
15.7.4.4.2. Academic and Research Institutes
15.7.4.4.3. Others
15.7.4.5. New Zealand Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.4.5.1. Online
15.7.4.5.2. Offline
15.7.5. Australia
15.7.5.1. Australia Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
15.7.5.1.1. Exosomes Tools and Kits
15.7.5.1.2. Exosomes Reagents
15.7.5.1.3. Exosomes Antibodies
15.7.5.1.4. Others
15.7.5.2. Australia Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.5.2.1. Diagnostics
15.7.5.2.2. Therapeutic
15.7.5.3. Australia Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
15.7.5.3.1. Cancer
15.7.5.3.2. Cardiovascular
15.7.5.3.3. Endocrinology
15.7.5.3.4. Neurodegenerative Diseases
15.7.5.3.5. Infectious Diseases
15.7.5.3.6. Others
15.7.5.4. Australia Exosomes Market Revenue (US$ Mn) and Forecasts, By
End User
15.7.5.4.1. Pharmaceutical and Biotechnology Companies
15.7.5.4.2. Academic and Research Institutes
15.7.5.4.3. Others
15.7.5.5. Australia Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.5.5.1. Online
15.7.5.5.2. Offline
15.7.6. South
Korea
15.7.6.1. South Korea Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
15.7.6.1.1. Exosomes Tools and Kits
15.7.6.1.2. Exosomes Reagents
15.7.6.1.3. Exosomes Antibodies
15.7.6.1.4. Others
15.7.6.2. South Korea Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.6.2.1. Diagnostics
15.7.6.2.2. Therapeutic
15.7.6.3. South Korea Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
15.7.6.3.1. Cancer
15.7.6.3.2. Cardiovascular
15.7.6.3.3. Endocrinology
15.7.6.3.4. Neurodegenerative Diseases
15.7.6.3.5. Infectious Diseases
15.7.6.3.6. Others
15.7.6.4. South Korea Exosomes Market Revenue (US$ Mn) and Forecasts, By
End User
15.7.6.4.1. Pharmaceutical and Biotechnology Companies
15.7.6.4.2. Academic and Research Institutes
15.7.6.4.3. Others
15.7.6.5. South Korea Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.7.6.5.1. Online
15.7.6.5.2. Offline
15.7.7. Southeast
Asia
15.7.7.1. Southeast Asia Exosomes Market Revenue (US$ Mn) and Forecasts,
By Offering
15.7.7.1.1. Exosomes Tools and Kits
15.7.7.1.2. Exosomes Reagents
15.7.7.1.3. Exosomes Antibodies
15.7.7.1.4. Others
15.7.7.2. Southeast Asia Exosomes Market Revenue (US$ Mn) and Forecasts,
By Application
15.7.7.2.1. Diagnostics
15.7.7.2.2. Therapeutic
15.7.7.3. Southeast Asia Exosomes Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
15.7.7.3.1. Cancer
15.7.7.3.2. Cardiovascular
15.7.7.3.3. Endocrinology
15.7.7.3.4. Neurodegenerative Diseases
15.7.7.3.5. Infectious Diseases
15.7.7.3.6. Others
15.7.7.4. Southeast Asia Exosomes Market Revenue (US$ Mn) and Forecasts,
By End User
15.7.7.4.1. Pharmaceutical and Biotechnology Companies
15.7.7.4.2. Academic and Research Institutes
15.7.7.4.3. Others
15.7.7.5. Southeast Asia Exosomes Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.7.7.5.1. Online
15.7.7.5.2. Offline
15.7.7.6. Southeast Asia Exosomes Market Revenue (US$ Mn) and Forecasts,
By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest of Asia Pacific Exosomes Market Revenue (US$ Mn) and
Forecasts, By Offering
15.7.8.1.1. Exosomes Tools and Kits
15.7.8.1.2. Exosomes Reagents
15.7.8.1.3. Exosomes Antibodies
15.7.8.1.4. Others
15.7.8.2. Rest of Asia Pacific Exosomes Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.8.2.1. Diagnostics
15.7.8.2.2. Therapeutic
15.7.8.3. Rest of Asia Pacific Exosomes Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
15.7.8.3.1. Cancer
15.7.8.3.2. Cardiovascular
15.7.8.3.3. Endocrinology
15.7.8.3.4. Neurodegenerative Diseases
15.7.8.3.5. Infectious Diseases
15.7.8.3.6. Others
15.7.8.4. Rest of Asia Pacific Exosomes Market Revenue (US$ Mn) and
Forecasts, By End User
15.7.8.4.1. Pharmaceutical and Biotechnology Companies
15.7.8.4.2. Academic and Research Institutes
15.7.8.4.3. Others
15.7.8.5. Rest of Asia Pacific Exosomes Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.7.8.5.1. Online
15.7.8.5.2. Offline
15.8. Key
Segment for Channeling Investments
15.8.1. By
Country
15.8.2. By Offering
15.8.3. By
Application
15.8.4. By
Disease Indication
15.8.5. By End
User
15.8.6. By
Distribution Channel
16. Middle East and Africa Exosomes Market Analysis and
Forecasts, 2022 - 2030
16.1. Overview
16.1.1. Middle
East and Africa Exosomes Market Revenue (US$ Mn)
16.2. Middle
East and Africa Exosomes Market Revenue (US$ Mn) and Forecasts, By Offering
16.2.1. Exosomes
Tools and Kits
16.2.2. Exosomes
Reagents
16.2.3. Exosomes
Antibodies
16.2.4. Others
16.3. Middle
East and Africa Exosomes Market Revenue (US$ Mn) and Forecasts, By Application
16.3.1. Diagnostics
16.3.2. Therapeutic
16.4. Middle
East and Africa Exosomes Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
16.4.1. Cancer
16.4.2. Cardiovascular
16.4.3. Endocrinology
16.4.4. Neurodegenerative
Diseases
16.4.5. Infectious
Diseases
16.4.6. Others
16.5. Middle
East and Africa Exosomes Market Revenue (US$ Mn) and Forecasts, By End User
16.5.1. Pharmaceutical
and Biotechnology Companies
16.5.2. Academic
and Research Institutes
16.5.3. Others
16.6. Middle
East and Africa Exosomes Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.6.1. Online
16.6.2. Offline
16.7. Middle
East and Africa Exosomes Market Revenue (US$ Mn) and Forecasts, By Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi Arabia Exosomes Market Revenue (US$ Mn) and Forecasts,
By Offering
16.7.1.1.1. Exosomes Tools and Kits
16.7.1.1.2. Exosomes Reagents
16.7.1.1.3. Exosomes Antibodies
16.7.1.1.4. Others
16.7.1.2. Saudi Arabia Exosomes Market Revenue (US$ Mn) and Forecasts,
By Application
16.7.1.2.1. Diagnostics
16.7.1.2.2. Therapeutic
16.7.1.3. Saudi Arabia Exosomes Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
16.7.1.3.1. Cancer
16.7.1.3.2. Cardiovascular
16.7.1.3.3. Endocrinology
16.7.1.3.4. Neurodegenerative Diseases
16.7.1.3.5. Infectious Diseases
16.7.1.3.6. Others
16.7.1.4. Saudi Arabia Exosomes Market Revenue (US$ Mn) and Forecasts,
By End User
16.7.1.4.1. Pharmaceutical and Biotechnology Companies
16.7.1.4.2. Academic and Research Institutes
16.7.1.4.3. Others
16.7.1.5. Saudi Arabia Exosomes Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
16.7.1.5.1. Online
16.7.1.5.2. Offline
16.7.2. UAE
16.7.2.1. UAE Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
16.7.2.1.1. Exosomes Tools and Kits
16.7.2.1.2. Exosomes Reagents
16.7.2.1.3. Exosomes Antibodies
16.7.2.1.4. Others
16.7.2.2. UAE Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.2.2.1. Diagnostics
16.7.2.2.2. Therapeutic
16.7.2.3. UAE Exosomes Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
16.7.2.3.1. Cancer
16.7.2.3.2. Cardiovascular
16.7.2.3.3. Endocrinology
16.7.2.3.4. Neurodegenerative Diseases
16.7.2.3.5. Infectious Diseases
16.7.2.3.6. Others
16.7.2.4. UAE Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
16.7.2.4.1. Pharmaceutical and Biotechnology Companies
16.7.2.4.2. Academic and Research Institutes
16.7.2.4.3. Others
16.7.2.5. UAE Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.2.5.1. Online
16.7.2.5.2. Offline
16.7.3. Egypt
16.7.3.1. Egypt Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
16.7.3.1.1. Exosomes Tools and Kits
16.7.3.1.2. Exosomes Reagents
16.7.3.1.3. Exosomes Antibodies
16.7.3.1.4. Others
16.7.3.2. Egypt Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.3.2.1. Diagnostics
16.7.3.2.2. Therapeutic
16.7.3.3. Egypt Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
16.7.3.3.1. Cancer
16.7.3.3.2. Cardiovascular
16.7.3.3.3. Endocrinology
16.7.3.3.4. Neurodegenerative Diseases
16.7.3.3.5. Infectious Diseases
16.7.3.3.6. Others
16.7.3.4. Egypt Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
16.7.3.4.1. Pharmaceutical and Biotechnology Companies
16.7.3.4.2. Academic and Research Institutes
16.7.3.4.3. Others
16.7.3.5. Egypt Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.3.5.1. Online
16.7.3.5.2. Offline
16.7.4. Kuwait
16.7.4.1. Kuwait Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
16.7.4.1.1. Exosomes Tools and Kits
16.7.4.1.2. Exosomes Reagents
16.7.4.1.3. Exosomes Antibodies
16.7.4.1.4. Others
16.7.4.2. Kuwait Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.4.2.1. Diagnostics
16.7.4.2.2. Therapeutic
16.7.4.3. Kuwait Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
16.7.4.3.1. Cancer
16.7.4.3.2. Cardiovascular
16.7.4.3.3. Endocrinology
16.7.4.3.4. Neurodegenerative Diseases
16.7.4.3.5. Infectious Diseases
16.7.4.3.6. Others
16.7.4.4. Kuwait Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
16.7.4.4.1. Pharmaceutical and Biotechnology Companies
16.7.4.4.2. Academic and Research Institutes
16.7.4.4.3. Others
16.7.4.5. Kuwait Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.7.4.5.1. Online
16.7.4.5.2. Offline
16.7.5. South
Africa
16.7.5.1. South Africa Exosomes Market Revenue (US$ Mn) and Forecasts,
By Offering
16.7.5.1.1. Exosomes Tools and Kits
16.7.5.1.2. Exosomes Reagents
16.7.5.1.3. Exosomes Antibodies
16.7.5.1.4. Others
16.7.5.2. South Africa Exosomes Market Revenue (US$ Mn) and Forecasts,
By Application
16.7.5.2.1. Diagnostics
16.7.5.2.2. Therapeutic
16.7.5.3. South Africa Exosomes Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
16.7.5.3.1. Cancer
16.7.5.3.2. Cardiovascular
16.7.5.3.3. Endocrinology
16.7.5.3.4. Neurodegenerative Diseases
16.7.5.3.5. Infectious Diseases
16.7.5.3.6. Others
16.7.5.4. South Africa Exosomes Market Revenue (US$ Mn) and Forecasts,
By End User
16.7.5.4.1. Pharmaceutical and Biotechnology Companies
16.7.5.4.2. Academic and Research Institutes
16.7.5.4.3. Others
16.7.5.5. South Africa Exosomes Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
16.7.5.5.1. Online
16.7.5.5.2. Offline
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest of Middle East & Africa Exosomes Market Revenue (US$
Mn) and Forecasts, By Offering
16.7.6.1.1. Exosomes Tools and Kits
16.7.6.1.2. Exosomes Reagents
16.7.6.1.3. Exosomes Antibodies
16.7.6.1.4. Others
16.7.6.2. Rest of Middle East & Africa Exosomes Market Revenue (US$
Mn) and Forecasts, By Application
16.7.6.2.1. Diagnostics
16.7.6.2.2. Therapeutic
16.7.6.3. Rest of Middle East & Africa Exosomes Market Revenue (US$
Mn) and Forecasts, By Disease Indication
16.7.6.3.1. Cancer
16.7.6.3.2. Cardiovascular
16.7.6.3.3. Endocrinology
16.7.6.3.4. Neurodegenerative Diseases
16.7.6.3.5. Infectious Diseases
16.7.6.3.6. Others
16.7.6.4. Rest of Middle East & Africa Exosomes Market Revenue (US$
Mn) and Forecasts, By End User
16.7.6.4.1. Pharmaceutical and Biotechnology Companies
16.7.6.4.2. Academic and Research Institutes
16.7.6.4.3. Others
16.7.6.5. Rest of Middle East & Africa Exosomes Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
16.7.6.5.1. Online
16.7.6.5.2. Offline
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By
Offering
16.8.3. By
Application
16.8.4. By
Disease Indication
16.8.5. By End
User
16.8.6. By
Distribution Channel
17. Latin America Exosomes Market Analysis and Forecasts, 2022 -
2030
17.1. Overview
17.1.1. Latin
America Exosomes Market Revenue (US$ Mn)
17.2. Latin
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Offering
17.2.1. Exosomes
Tools and Kits
17.2.2. Exosomes
Reagents
17.2.3. Exosomes
Antibodies
17.2.4. Others
17.3. Latin
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Application
17.3.1. Diagnostics
17.3.2. Therapeutic
17.4. Latin
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Disease Indication
17.4.1. Cancer
17.4.2. Cardiovascular
17.4.3. Endocrinology
17.4.4. Neurodegenerative
Diseases
17.4.5. Infectious
Diseases
17.4.6. Others
17.5. Latin
America Exosomes Market Revenue (US$ Mn) and Forecasts, By End User
17.5.1. Pharmaceutical
and Biotechnology Companies
17.5.2. Academic
and Research Institutes
17.5.3. Others
17.6. Latin
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
17.6.1. Online
17.6.2. Offline
17.7. Latin
America Exosomes Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
17.7.1.1.1. Exosomes Tools and Kits
17.7.1.1.2. Exosomes Reagents
17.7.1.1.3. Exosomes Antibodies
17.7.1.1.4. Others
17.7.1.2. Brazil Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.1.2.1. Diagnostics
17.7.1.2.2. Therapeutic
17.7.1.3. Brazil Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
17.7.1.3.1. Cancer
17.7.1.3.2. Cardiovascular
17.7.1.3.3. Endocrinology
17.7.1.3.4. Neurodegenerative Diseases
17.7.1.3.5. Infectious Diseases
17.7.1.3.6. Others
17.7.1.4. Brazil Exosomes Market Revenue (US$ Mn) and Forecasts, By End
User
17.7.1.4.1. Pharmaceutical and Biotechnology Companies
17.7.1.4.2. Academic and Research Institutes
17.7.1.4.3. Others
17.7.1.5. Brazil Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.7.1.5.1. Online
17.7.1.5.2. Offline
17.7.2. Argentina
17.7.2.1. Argentina Exosomes Market Revenue (US$ Mn) and Forecasts, By
Offering
17.7.2.1.1. Exosomes Tools and Kits
17.7.2.1.2. Exosomes Reagents
17.7.2.1.3. Exosomes Antibodies
17.7.2.1.4. Others
17.7.2.2. Argentina Exosomes Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.2.2.1. Diagnostics
17.7.2.2.2. Therapeutic
17.7.2.3. Argentina Exosomes Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
17.7.2.3.1. Cancer
17.7.2.3.2. Cardiovascular
17.7.2.3.3. Endocrinology
17.7.2.3.4. Neurodegenerative Diseases
17.7.2.3.5. Infectious Diseases
17.7.2.3.6. Others
17.7.2.4. Argentina Exosomes Market Revenue (US$ Mn) and Forecasts, By
End User
17.7.2.4.1. Pharmaceutical and Biotechnology Companies
17.7.2.4.2. Academic and Research Institutes
17.7.2.4.3. Others
17.7.2.5. Argentina Exosomes Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.7.2.5.1. Online
17.7.2.5.2. Offline
17.7.3. Rest of
Latin America
17.7.3.1. Rest of Latin America Exosomes Market Revenue (US$ Mn) and
Forecasts, By Offering
17.7.3.1.1. Exosomes Tools and Kits
17.7.3.1.2. Exosomes Reagents
17.7.3.1.3. Exosomes Antibodies
17.7.3.1.4. Others
17.7.3.2. Rest of Latin America Exosomes Market Revenue (US$ Mn) and
Forecasts, By Application
17.7.3.2.1. Diagnostics
17.7.3.2.2. Therapeutic
17.7.3.3. Rest of Latin America Exosomes Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
17.7.3.3.1. Cancer
17.7.3.3.2. Cardiovascular
17.7.3.3.3. Endocrinology
17.7.3.3.4. Neurodegenerative Diseases
17.7.3.3.5. Infectious Diseases
17.7.3.3.6. Others
17.7.3.4. Rest of Latin America Exosomes Market Revenue (US$ Mn) and
Forecasts, By End User
17.7.3.4.1. Pharmaceutical and Biotechnology Companies
17.7.3.4.2. Academic and Research Institutes
17.7.3.4.3. Others
17.7.3.5. Rest of Latin America Exosomes Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.7.3.5.1. Online
17.7.3.5.2. Offline
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By
Offering
17.8.3. By
Application
17.8.4. By
Disease Indication
17.8.5. By End
User
17.8.6. By Distribution
Channel
18. Competitive Benchmarking
18.1. Market
Share Analysis, 2021
18.2. Global
Presence and Growth Strategies
18.2.1. Mergers
and Acquisitions
18.2.2. Product
Launches
18.2.3. Investments
Trends
18.2.4. R&D
Initiatives
19. Player Profiles
19.1. AMSBIO
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. BioVision
Inc.
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business
Strategies
19.3. ExoDx
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT
Analysis
19.3.7. Business
Strategies
19.4. FUJIFILM
Wako Pure Chemical Corporation
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. Lonza
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. Miltenyi
Biotec
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. Norgen
Biotek Corp.
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key
Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. QIAGEN
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT Analysis
19.8.7. Business
Strategies
19.9. System
Biosciences, LLC
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. Takara
Bio Inc.
19.10.1. Company
Details
19.10.2. Company
Overview
19.10.3. Product
Offerings
19.10.4. Key
Developments
19.10.5. Financial
Analysis
19.10.6. SWOT
Analysis
19.10.7. Business
Strategies
19.11. Thermo
Fisher Scientific
19.11.1. Company
Details
19.11.2. Company
Overview
19.11.3. Product
Offerings
19.11.4. Key
Developments
19.11.5. Financial
Analysis
19.11.6. SWOT
Analysis
19.11.7. Business
Strategies
19.12. ZenBio,
Inc.
19.12.1. Company
Details
19.12.2. Company
Overview
19.12.3. Product
Offerings
19.12.4. Key
Developments
19.12.5. Financial
Analysis
19.12.6. SWOT
Analysis
19.12.7. Business Strategies
19.13. Other
Market Participants
20. Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.